Armodafinil 150mg Tablet

Armodafinil 150mg Tablet is a prescription wakefulness-promoting medicine used to improve wakefulness in adults with excessive sleepiness associated with narcolepsy, obstructive sleep apnea (OSA), or shift work disorder (SWD). Armodafinil is the generic medicine name; Nuvigil® is a branded armodafinil product. The 150mg strength is an established tablet strength and is also the labeled strength for shift work disorder in the U.S.

Product Information

Generic Name

Armodafinil

Strength

150mg

Dosage Form

Oral Tablet

Drug Class

Wakefulness-Promoting Agent (Eugeroic)

Reference Brand

Nuvigil® / Waklert

Indications

Narcolepsy, obstructive sleep apnea (OSA), and shift work disorder (SWD)

Route

Oral

Prescription Status

Prescription medicine

U.S. Controlled-Substance Status

Schedule IV (C-IV)

Armodafinil 150mg vs Nuvigil®

Armodafinil is the generic medicine/active ingredient, while Nuvigil® is a brand product containing armodafinil.

Therefore:

Armodafinil 150mg Tablet → Generic medicine → Nuvigil® is a reference/brand product

The phrase “generic Nuvigil” should only be used where the particular product is legally marketed as an equivalent generic in the relevant jurisdiction.

Armodafinil 150mg vs Modafinil

Armodafinil and modafinil are closely related wakefulness-promoting medicines but are not identical products. Armodafinil contains the R-enantiomer of modafinil, whereas modafinil contains both R- and S-enantiomers.

They have overlapping clinical uses, including excessive sleepiness associated with narcolepsy, OSA, and shift work disorder, but they should not be treated as interchangeable without professional medical advice.

How it works

Armodafinil promotes wakefulness through effects on brain pathways involved in alertness. It is the R-enantiomer of modafinil and has a pharmacological profile distinct from traditional amphetamine-type stimulants.

The precise mechanism responsible for its wakefulness-promoting effects is not completely established. It is prescribed primarily to improve wakefulness rather than to treat the underlying cause of a sleep disorder.

Armodafinil 150mg is prescribed to improve wakefulness in adults experiencing excessive sleepiness associated with:

Narcolepsy

Armodafinil may be prescribed to improve daytime wakefulness in adults with narcolepsy, a neurological sleep disorder characterized by excessive daytime sleepiness.

Obstructive Sleep Apnea

Armodafinil can be used to address excessive sleepiness associated with obstructive sleep apnea. It does not treat the underlying airway obstruction; appropriate treatment of the underlying OSA remains important.

Shift Work Disorder

Armodafinil 150mg is indicated for improving wakefulness in adults with excessive sleepiness associated with shift work disorder.

Armodafinil can cause clinically important adverse reactions. Serious reactions reported with armodafinil and related medicines include severe skin reactions such as Stevens-Johnson syndrome, DRESS/multiorgan hypersensitivity, angioedema, and anaphylaxis. Psychiatric symptoms and cardiovascular concerns may also require clinical monitoring.

Patients should seek immediate medical attention for symptoms suggestive of a serious allergic reaction or severe skin reaction.

Armodafinil is contraindicated in patients with known hypersensitivity to armodafinil, modafinil, or relevant inactive ingredients.